About this platform

The JA GHI project

JA GHI – European Joint Action to Maximise the Impact of the EU Global Health Strategy is a three-year initiative co-funded by the European Union under the EU4Health programme (Grant Agreement No. 101140722), active from October 2023.

The project brings together 24 countries across Europe, including Norway and Ukraine – ministries of health, national public health institutes, research universities and affiliated entities – with the shared goal of reinforcing EU leadership in global health. It does so by building rolling coordination mechanisms between EU institutions and Member States, promoting the Team Europe approach, and strengthening the visibility of European contributions to global health.

JA GHI’s core workstreams include: a dynamic mapping of measures and funding aligned with the EU Global Health Strategy (2022–2030); improved coordination platforms and digital tools to support unified EU positions in international fora (WHO, G7, G20); and a comprehensive external communication plan to ensure that Europe’s collective action in global health is well understood and broadly recognised.

For full information on the project structure, partners and expected outcomes, visit the official JA GHI website.

About the survey

The data visualisations presented on this platform draw on a cross-national survey conducted as part of Work Package 7 (WP7) of the JA GHI project, focused on strengthening external communication on the EU’s contribution to global health.

The survey was developed in two stages. First, a structured stakeholder analysis was carried out across all participating countries, using a four-quadrant power–interest grid to identify and classify national institutions operating in global health according to their influence and level of engagement. The resulting stakeholder lists guided the targeted dissemination of the questionnaire.
The questionnaire itself covered four thematic areas: respondent profile and institutional context; awareness and knowledge of the EU Global Health Strategy; perceptions of its relevance and dissemination needs; and the governance landscape at national level, including coordination mechanisms and key actors.

 Data were collected between June and November 2024 via the EUSurvey platform, reaching 151 respondents from 20 countries, representing government and public authorities, academia, civil society, healthcare providers and the private sector.
Findings were subsequently validated with national JA GHI representatives through structured interviews or written feedback, ensuring that results were interpreted in light of each country’s institutional context.
For each country, the survey data were processed and compiled into a descriptive document providing a concise narrative synthesis of the main findings and contextual factors, which was shared with the country’s JA-GHI National Contact Person for validation.

 The survey was intended to set the baseline for stakeholders’ awareness and incorporation of the EU Global Health Strategy (2022–2030), so as to better define communication channels and tools for its dissemination. Building on the prior structured stakeholder analysis, the survey pursued four specific objectives: to assess stakeholders’ awareness and knowledge of the EU Global Health Strategy; to understand how the Strategy is perceived, interpreted and applied across different national and institutional contexts; to map the governance landscape in each participating country, including the existence of national Global Health strategies, Global Health Ambassadors and coordination mechanisms among key actors; and to identify perceived barriers and opportunities for strengthening the Strategy’s implementation and communication. Together, these objectives were designed to provide an evidence base supporting JA GHI’s broader mandate to reinforce EU leadership and coordination in global health.

 As with any survey-based study, some limitations should be considered when interpreting the results. The use of purposive sampling and national redistribution, with no central mechanism to monitor coverage, may have introduced selection bias and limits the generalisability of the findings; stakeholders already engaged in global health issues may be over-represented, potentially inflating estimates of awareness. The sample was also unevenly distributed across countries and, although a weighting procedure was applied to correct for this imbalance, some residual bias is likely. Data were self-reported and may be subject to recall or social-desirability bias, particularly regarding knowledge of national governance structures.
Following the validation process, two respondents initially attributed to Belgium were identified as International Non-Governmental Organisations (INGOs) rather than national institutions. As these respondents met the eligibility criteria but could not be reliably assigned to a single country, they were retained in the dataset and presented as a separate International Organizations category in country-stratified analyses, rather than being excluded and resulting in the loss of valid information.
Finally, the cross-sectional design does not allow for causal inference or for assessing changes over time.

The full methodology and results are presented in the Technical Report “From Strategy to Implementation: Results of a Cross-National Analysis of the Awareness, Knowledge and Alignment of European Stakeholders”.